These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12200189)

  • 41. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.
    Antkiewicz-Michaluk L; Romañska I; Papla I; Michaluk J; Bakalarz M; Vetulani J; Krygowska-Wajs A; Szczudlik A
    Neuroscience; 2000; 96(1):59-64. PubMed ID: 10683410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022.
    Maruyama W; Akao Y; Youdim MB; Naoi M
    J Neural Transm Suppl; 2000; (60):171-86. PubMed ID: 11205138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection.
    Naoi M; Maruyama W; Akao Y; Yi H; Yamaoka Y
    J Neural Transm Suppl; 2006; (71):67-77. PubMed ID: 17447417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No increase of synthesis of (R)salsolinol in Parkinson's disease.
    Müller T; Przuntek H; Kuhn W; Baum SS; Rommelspacher H
    Mov Disord; 1999 May; 14(3):514-5. PubMed ID: 10348481
    [No Abstract]   [Full Text] [Related]  

  • 45. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
    Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Takahashi A; Dostert P; Naoi M; Nagatsu T
    J Chromatogr; 1992 Jul; 578(1):109-15. PubMed ID: 1400775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease.
    Zhu W; Wang D; Zheng J; An Y; Wang Q; Zhang W; Jin L; Gao H; Lin L
    Clin Chem; 2008 Apr; 54(4):705-12. PubMed ID: 18238832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
    Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
    J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRPC1 protects dopaminergic SH-SY5Y cells from MPP+, salsolinol, and N-methyl-(R)-salsolinol-induced cytotoxicity.
    Arshad A; Chen X; Cong Z; Qing H; Deng Y
    Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):22-30. PubMed ID: 24252728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M; Dostert P; Yoshida M; Nagatsu T
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: the role of salsolinol and NM-salsolinol.
    Su Y; Duan J; Ying Z; Hou Y; Zhang Y; Wang R; Deng Y
    Neuroscience; 2013 Mar; 233():72-85. PubMed ID: 23291452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics.
    Musshoff F; Lachenmeier DW; Schmidt P; Dettmeyer R; Madea B
    Alcohol Clin Exp Res; 2005 Jan; 29(1):46-52. PubMed ID: 15654290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: a self-perpetuating crosstalk?
    Vairetti M; Ferrigno A; Rizzo V; Ambrosi G; Bianchi A; Richelmi P; Blandini F; Armentero MT
    Biochim Biophys Acta; 2012 Feb; 1822(2):176-84. PubMed ID: 22119596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(6):567-72. PubMed ID: 12866710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
    Youdim MB; Riederer P
    J Neural Transm Suppl; 1993; 40():57-67. PubMed ID: 8294901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains.
    Naoi M; Maruyama W; Matsubara K; Hashizume Y
    Neurosci Lett; 1997 Oct; 235(1-2):81-4. PubMed ID: 9389601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease.
    Plaitakis A; Shashidharan P
    J Neurol; 2000 Apr; 247 Suppl 2():II25-35. PubMed ID: 10991662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The molecular mechanisms of dopamine toxicity.
    Barzilai A; Daily D; Zilkha-Falb R; Ziv I; Offen D; Melamed E; Shirvan A
    Adv Neurol; 2003; 91():73-82. PubMed ID: 12442665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.